$40MRound, 30 October 2025
Funds clinical validation, commercialization and a pipeline of chronic disease tests.
- Amount
- $40M
- Announced
- 30 October 2025
- Lead
- Luma Group
- Other investors
- First Spark Ventures, Techas Capital, NZVC, LifeX Ventures
- Use of funds
- Funds clinical validation, commercialization and a pipeline of chronic disease tests.
- Checked
- Amount and date checked against the press source
- Source
- Curve Biosciences raises $40M (date approx) pulse2.com